August 10, 2017
Article
Despite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.
Investigating RBX2660 for Recurrent C Difficile Infection
Examining Oral Vancomycin as a First-Line CDI Therapy
The Latest on Monkeypox
Assessing Vancomycin and Metronidazole Susceptibility for CDI